Listen Now
Topics Covered
- Why Clinical Trials Are Important as a Treatment Option
- What Happens in a Clinical Trial
- New Research in the Treatment of Triple Negative Breast Cancer (TNBC)
- Investigational New Drugs in Clinical Trials
- The Meaning of Informed Consent
- Benefits & Risks of Participation
- How & Where Clinical Trials are Conducted
- How to Participate in Clinical Trials
- Specific Questions to Ask Your Health Care Team about Clinical Trials
- Accessing Resources for Clinical Trials
- Questions for Our Panel of Experts
Our Panel of Experts

Edith P. Mitchell, MD, MACP, FCPP
Clinical Professor of Medicine and Medical Oncology, Department of Medical Oncology, Director, Center to Eliminate Cancer Disparities, Associate Director, Diversity Affairs, Sidney Kimmel Cancer Center at Jefferson, 116th President National Medical Association

Preeti Sudheendra, MD
Hematologist/Oncologist, Medical Director of Quality Improvement, Cooper University Health Care, Cancer Genetics Program, Hematology and Medical Oncology, MD Anderson Cancer Center at Cooper, Assistant Professor of Medicine, Cooper Medical School of Rowan University

Roberto A. Leon-Ferre, MD
Assistant Professor, Department of Oncology, Mayo Clinic

Hayley Dinerman, JD
Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation®

Maryrose Mongelli, MSW
Women’s Cancers Program Coordinator, CancerCare
Brochure
You can download the brochure for this workshop(126 KB)
Workshop Date
This workshop was originally recorded on September 26, 2018.